Arbutus Biopharma Corporation

Canada


 
Total IP 189
Total IP incl. subs 225 (+ 36 for subs)
Total IP Rank # 6,801
IP Activity Score 2.9/5.0    127
IP Activity Rank # 5,415
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

91 0
51 0
43 0
4
 
Last Patent 2024 - Novel lipids and compositions fo...
First Patent 1999 - Sensitizing cells to compounds u...
Last Trademark 2024 - ARBUTUS
First Trademark 2017 - ARBUTUS

Subsidiaries

1 subsidiaries with IP (36 patents, 0 trademarks)

2 subsidiaries without IP

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same. The present inve...
G/S Pharmaceutical preparations for the treatment of hepatitis.
Invention Novel lipids and compositions for the delivery of therapeutics. The present invention provides l...
Invention Novel lipid formulations for delivery of therapeutic agents. The present invention provides nove...
Invention Improved methods for synthesis of 5-(aminomethyl)pyrrolidin-2-one compounds. The present disclosu...
Invention Lipid formulations for delivery of therapeutic agents. The present invention provides novel, seru...
Invention Non-liposomal systems for nucleic acid delivery. The present invention provides novel, stable lip...
2023 Invention Substituted arylamine compounds, substituted heteroarylamine compounds, and methods using same. T...
Invention Substituted 1-arylaminocarbonyl-1'-heteroaryl compounds, substituted 1-heteroarylaminocarbonyl-1'...
Invention Synthesis of substituted 1-aryl-1'-heteroaryl compounds and substituted 1,1'-biheteroaryl compoun...
Invention Synthesis of substituted tetracyclic carboxylic acids and analogues thereof. The present disclosu...
Invention Substituted imidazoamide compounds, and methods using same. The present disclosure includes subst...
Invention Non-liposomal systems for nucleic acid delivery. The present invention provides novel, stable li...
Invention Lipid formulations for nucleic acid delivery. The present invention provides novel, stable lipid...
Invention Lipids and compositions for the delivery of therapeutics. The present invention provides lipids t...
Invention Lipid compositions. Disclosed herein are lipid compositions comprising a cationic lipid of formul...
Invention Rna polymerase inhibitors and methods using same. The present disclosure relates to compounds of ...
2022 Invention Pro) inhibitors and methods using same. The present disclosure relates to compounds, and composit...
Invention Synthesis of substituted tricyclic amides and analogues thereof. The present disclosure includes...
Invention Synthesis of substituted tricyclic amides and analogues thereof. The present disclosure includes ...
Invention Targeted compositions. The invention provides certain nucleic acids (e.g., double stranded siRNA ...
Invention Methods for ameliorating infusion reactions. Certain embodiments of the invention provide methods...
Invention Substituted tetracyclic carboxylic acids, analogues thereof, and methods using same. The present ...
Invention Substituted 1-aryl-1’-heteroaryl compounds, substituted 1,1’-biheteroaryl compounds, and methods ...
Invention Substituted 1-aryl-1'-heteroaryl compounds, substituted 1,1'-biheteroaryl compounds, and methods ...
2021 Invention Targeted conjugates comprising modified sirna. The invention provides certain nucleic acids (e.g....
Invention Lipids and compositions for the delivery of therapeutics. 10 alkynyl, alkylhetrocycle, alkylphosp...
Invention Synthesis of substituted arylmethylureas, analogues, and crystalline forms thereof and methods of...
Invention Substituted (phthalazin-1-ylmethyl)ureas, substituted n-(phthalazin-1-ylmethyl)amides, and analog...
Invention Substituted isoquinolinylmethyl amides, analogues thereof, and methods using same. The present d...
Invention Substituted isoquinolinylmethyl amides, analogues thereof, and methods using same. The present di...
Invention Substituted tricyclic amides, analogues thereof, and methods using same. The present invention i...
Invention Methods of delivering oligonucleotides to immune cells. The invention relates to the field of de...
Invention Lipid compositions. Disclosed herein are lipid compositions comprising a cationic lipid of formu...
2020 Invention Substituted bicyclic and tricyclic ureas and amides, analogues thereof, and methods using same. ...
Invention Substituted isoindolonyl 2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same....
Invention Substituted cyclopropyl-2,2'-bipyrimidinyl compounds, analogues thereof, and methods using same. ...
Invention Substituted polycyclic carboxylic acids, analogues thereof, and methods using same. The present ...
2019 Invention Substituted arylmethylureas and heteroarylmethylureas, analogues thereof, and methods using same....
Invention Cationic lipids containing silicon. Certain embodiments of the invention provide a cationic lipi...
Invention Negatively charged peg-lipid conjugates. The invention provides PEG-conjugated lipids of formula...
Invention Lipid nanoparticle formulations. The invention provides certain specific lipid nanoparticles com...
Invention Bivalent targeted conjugates. The invention provides conjugates that comprise a bivalent targeti...
2018 Invention Therapeutic compositions and methods for treating hepatitis b. The invention provides therapeuti...
2017 G/S Drug discovery for others in the nature of pharmaceutical research and development.